Status:
UNKNOWN
NT-proBNP Measurements to Rule-out Heart Failure Among Patients With Atrial Fibrillation: A Prospective Clinical Study
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Randers Regional Hospital
Conditions:
Atrial Fibrillation
Heart Failure
Eligibility:
All Genders
Brief Summary
This study aims to investigate N-terminal pro brain natriuretic peptide (NT-proBNP) as a biomarker to rule out heart failure in patients with atrial fibrillation. Atrial fibrillation and heart failure...
Detailed Description
Background and hypothesis: Atrial fibrillation is the most common cardiac arrhythmia with a prevalence of approximately 2% in the general population and even higher among elderlies. Atrial fibrillati...
Eligibility Criteria
Inclusion
- Admission to hospital with atrial fibrillation
- On-going atrial fibrillation documented on an ECG
Exclusion
- \<18 years
- Other arrhythmias than atrial fibrillation
- Hemodynamically unstable
- Terminal renal failure (in dialysis)
- Pregnancy
Key Trial Info
Start Date :
November 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
403 Patients enrolled
Trial Details
Trial ID
NCT04125966
Start Date
November 11 2019
End Date
March 1 2021
Last Update
October 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Randers Regional Hospital
Randers, Denmark, 8930